{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:44:17Z","timestamp":1795088657541,"version":"4.10.2"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2012,3,20]]},"DOI":"10.1212\/wnl.0b013e31824c4634","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T07:04:43Z","timestamp":1329980683000},"page":"921-927","source":"Crossref","is-referenced-by-count":28,"title":["Lamotrigine and aseptic meningitis"],"prefix":"10.1212","volume":"78","author":[{"given":"Kelley M.","family":"Simms","sequence":"first","affiliation":[{"name":"From the Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Kortepeter","sequence":"additional","affiliation":[{"name":"From the Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Avigan","sequence":"additional","affiliation":[{"name":"From the Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_7_2_2","unstructured":"Mandell GL Douglas RG Bennett JE Dolin R . Mandell Douglas and Bennett's Principles and Practice of Infectious Diseases 6th ed. New York: Elsevier\/Churchill Livingstone; 2005."},{"key":"e_1_3_7_3_2","unstructured":"Kaplan JL Porter R . Meningitis. In: The Merck Manual of Diagnosis and Therapy. Available at: http:\/\/www.merck.com\/mmpe\/index.html. Accessed October 8 2009."},{"key":"e_1_3_7_4_2","unstructured":"Lamotrigine (Lamictal\u00ae) tablets prescribing information. Research Triangle Park NC: GlaxoSmithKline; May 2009."},{"key":"e_1_3_7_5_2","unstructured":"Food and Drug Administration. Briefing information for the December 7 2010 Meeting of the Pediatric Advisory Committee. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/PediatricAdvisoryCommittee\/UCM234466.pdf. Accessed June 3 2011."},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241100-00001"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703337"},{"key":"e_1_3_7_8_2","unstructured":"Food and Drug Administration. Adverse event reporting system (AERS). Available at: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/default.htm. Accessed May 11 2010."},{"key":"e_1_3_7_9_2","unstructured":"Code of Federal Regulations Title 21 Volume 5 revised April 1 2009. 21 CFR 314.80: Postmarketing reporting of adverse drug experiences. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=314.80. Accessed October 14 2009."},{"key":"e_1_3_7_10_2","unstructured":"European Medicines Agency. Guideline on the use of statistical signal detection methods in Eudravigilance data analysis system. Available at: http:\/\/www.emea.europa.eu\/pdfs\/human\/phvwp\/10646406en.pdf. Accessed January 28 2011."},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225060-00001"},{"key":"e_1_3_7_13_2","unstructured":"MedDRA MSSO and Northrop Grumman. MedDRA. Available at: http:\/\/www.meddramsso.com. Accessed October 14 2009."},{"key":"e_1_3_7_14_2","unstructured":"Carbamazepine USP (Tegretol\u00ae) prescribing information. East Hanover NJ: Novartis Pharmaceuticals Corporation; 2009."},{"key":"e_1_3_7_15_2","article-title":"Syndrome d'hypersensibilite et lupus induit par la lamotrigine","volume":"24","author":"Grenouillet M","year":"2003","unstructured":"Grenouillet M, Camou F, Guisset O , et al. . Syndrome d'hypersensibilite et lupus induit par la lamotrigine. Rev Mid Intern 2003; 24 (suppl 4): 486s.","journal-title":"Rev Mid Intern"},{"key":"e_1_3_7_16_2","first-page":"140","article-title":"Lamotrigine-induced hypersensitivity syndrome accompanied with aseptic meningitis","volume":"27","author":"Lee SH","year":"2007","unstructured":"Lee SH, Yang MS, Kim T , et al. . Lamotrigine-induced hypersensitivity syndrome accompanied with aseptic meningitis. J Asthma Allergy Clin Immunol 2007; 27: 140\u2013 142.","journal-title":"J Asthma Allergy Clin Immunol"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01960.x"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e31819f9544"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2005.43304.x"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32832a8edc"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01985.x"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5089-3"},{"key":"e_1_3_7_23_2","unstructured":"Ramachandran TS . Aseptic meningitis. Available at: http:\/\/emedicine.medscape.com\/article\/1169489-overview. Accessed January 24 2011."},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.2174\/1568008033340243"},{"key":"e_1_3_7_25_2","unstructured":"FDA. FDA Drug Safety Communication: aseptic meningitis associated with use of Lamictal (lamotrigine). Available at: http:\/\/www.fda.gov. Accessed August 12 2010."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.0b013e31824c4634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:03:08Z","timestamp":1711630988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0b013e31824c4634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,20]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,3,20]]}},"alternative-id":["10.1212\/WNL.0b013e31824c4634"],"URL":"https:\/\/doi.org\/10.1212\/wnl.0b013e31824c4634","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,20]]}}}